OBEZİTEYE MOLEKÜLER YAKLAŞIM
Synopsis
This section addresses the molecular mechanisms of obesity, focusing on the roles of leptin and melatonin hormones, the impacts of primary cilia, as well as genetic and epigenetic factors. Obesity is a multifactorial disease resulting from an imbalance between energy intake and expenditure. Leptin, secreted by adipose tissue, regulates appetite and energy homeostasis by modulating NPY/AgRP and POMC neurons in the hypothalamus. Binding of leptin to the LEPRb receptor activates the JAK2/STAT3 pathway, which increases the synthesis of appetite-suppressing molecules while repressing orexigenic neuropeptides. However, defects in leptin transport, reduced LEPRb cell-surface expression, or the upregulation of negative regulators like SOCS3 contribute to leptin resistance and obesity. Melatonin, secreted by the pineal gland, regulates circadian rhythms, glucose metabolism, and adipose tissue functions via MT1/MT2 receptors in the SCN and peripheral tissues. Additionally, dysfunction of primary cilia in ciliopathies such as Bardet-Biedl and Alström syndromes triggers obesity development. Genetically, obesity is classified into monogenic, polygenic, and syndromic types like Prader-Willi, while epigenetic mechanisms—including DNA methylation, histone modifications, and non-coding RNAs driven by environmental factors—alter gene expression and play a critical role in obesity pathogenesis
References
Engle SE, Bansal R, Antonellis PJ, Berbari NF. Cilia signaling and obesity. Semin Cell Dev Biol. 2021;110(February):43–50.
Zhou Y and Rui L. Leptin signaling and leptin resistance. Front Med. 2013;7(2):207–22.
Paracchini V, Pedotti P, Taioli E. Genetics of Leptin and Obesity. Am J Epidemiol. 2005;162(2):101–14.
Singh RK, Kumar P, Mahalingam K. Molecular genetics of human obesity: A comprehensive review. Comptes Rendus - Biol [Internet]. 2017;340(2):87–108.
Gregor MF, Hotamisligil GS. Inflammatory mechanisms in obesity. Annu Rev Immunol. 2011;29:415–45.
T.C. Sağlık Bakanlığı. Türkiye’de Obezitenin Görülme Sıklığı. https://hsgm.saglik.gov.tr/tr/obezite/turkiyede-obezitenin-gorulme-sikligi.html#:~:text=T%C3%BCrkiye’de%20obezite%20s%C4%B1kl%C4%B1%C4%9F%C4%B1%3B,Toplamda%20%25%2030%2C3. 2010.
Schwartz MW, Woods SC, Jr DP, Seeley RJ, Baskin DG. Central nervous system control of food intake. Nature. 2000;404:661–71.
A Guilherme, F Henriques, Alexander H. Bedard MPC. Molecular pathways linking adipose innervation to insulin sensitivity in obesity and type 2 diabetes Adilson. Nat Rev Endocrinol. 2019;15(4):207–25.
Myers MG, Cowley MA, Münzberg H. Mechanisms of leptin action and leptin resistance. Annu Rev Physiol. 2008;70:537–56.
Vaisse C, Reiter JF, Berbari NF. Cilia and obesity. Cold Spring Harb Perspect Biol. 2017;9(7):1–13.
Zhou Y RL. Leptin Signalings and Leptin Resistance. Front Med. 2013;7(2):207–22.
Friedman JM, Halaas JL. Leptin and the regulation of body weight in mammals. Nature. 1998;395:763–70.
Morris DL, Rui L, Morris DL, Rui L. Recent advances in understanding leptin signaling and leptin resistance Recent advances in understanding leptin signaling and leptin resistance. Am J Physiol - Endocrinol Metab. 2012;297(Sept):E1247–59.
Hong Fei, Hirotaka J. Okano, Cai Li, Gwo-Hwa Lee, Connie Zhao, Robert Darnell JMF. Anatomic localization of alternatively spliced leptin receptors ( Ob-R ) in mouse brain and other tissues. ProcNatlAcadSci. 1997;94(June):7001–5.
Kaszubska W, Falls HD, Schaefer VG, Haasch D, Frost L, Hessler P, et al. Protein tyrosine phosphatase 1B negati v ely regulates leptin signaling in a hypothalamic cell line. Mol Cell Endocrinol. 2002;195:109–18.
Crujeiras AB, Carreira MC, Cabia B, Andrade S, Amil M, Casanueva FF. Leptin resistance in obesity: An epigenetic landscape. Life Sci [Internet]. 2015;140:57–63.
Coppari R, Bjørbæk C. Leptin revisited: Its mechanism of action and potential for treating diabetes. Nat Rev Drug Discov. 2012;11(9):692–708.
Kastin AJ, Pan W, Maness LM, Koletsky RJ, Ernsberger P. Decreased transport of leptin across the blood-brain barrier in rats lacking the short form of the leptin receptor. Peptides. 1999;20(12):1449–53.
Banks WA, DiPalma CR, Farrell CL. Impaired transport of leptin across the blood-brain barrier in obesity. Peptides. 1999;20(11):1341–5.
Maffei M., J. Ravussin Halaas, E., Pratley R.E. , Lee G.H., Zhang Y., Fei H., Kim S., Lallone R , Ranganathan S. KPA& FJM. Leptin levels in human and rodent: Measurement of plasma leptin and ob RNA in obese and weight-reduced subjects. Nat Med. 1995;1:1155–61.
Xu B, Goulding EH, Zang K, Cepoi D, Cone RD, Kevin R, et al. Brain-derived neurotrophic factor regulates energy balance downstream of melanocortin-4 receptor. Nat Neurosci. 2009;6(7):736–42.
Quan W, Kim H, Moon E, Kim SS, Choi CS, Komatsu M, et al. Role of Hypothalamic Proopiomelanocortin Neuron Autophagy in the Control of Appetite and Leptin Response. Neuroendocrinology. 2012;153(April):1817–26.
Karamitri A, Jockers R. Melatonin in type 2 diabetes mellitus and obesity. Nat Rev Endocrinol [Internet]. 2019;15(2):105–25. Available from: http://dx.doi.org/10.1038/s41574-018-0130-1
Jockers R, Delagrange P, Dubocovich ML, Markus RP, Renault N, Tosini G, et al. Update on melatonin receptors: IUPHAR Review 20. Br J Pharmacol. 2016;2702–25.
Legros C, Chesneau D, Boutin JA, Barc C, Malpaux B. Melatonin from cerebrospinal fluid but not from blood reaches sheep cerebral tissues under physiological conditions. J Neuroendocrinol. 2014;26(3):151–63.
Cecon E, Oishi A, Jockers R. Melatonin receptors: molecular pharmacology and signalling in the context of system bias. Br J Pharmacol. 2018;175(16):3263–80.
Zalatan F, Krause JA, Blask DE. Inhibition of isoproterenol-induced lipolysis in rat inguinal adipocytes in vitro by physiological melatonin via a receptor-mediated mechanism. Endocrinology. 2001;142(9):3783–90.
Özbayer C. ve Değirmenci İ. Sirkadiyen saat, hücre döngüsü ve kanser. Dicle Tıp Derg. 2011;38(4):514–8.
Cipolla-Neto J, Amaral FG, Afeche SC, Tan DX, Reiter RJ. Melatonin, energy metabolism, and obesity: A review. J Pineal Res. 2014;56(4):371–81.
Tuomi T, Nagorny CLF, Singh P, Bennet H, Yu Q, Alenkvist I, et al. Increased Melatonin Signaling Is a Risk Factor for Type 2 Diabetes. Cell Metab. 2016;23(6):1067–77.
Değirmenci İ. Diyabette Sillerin Rolü. Editor: Özyiğit F, Diyabete Multidisipliner Yaklaşım. 1st ed. Ankara: Akademisyen Kitabevi; 2020. p. 225–36.
Forsythe E, Kenny J, Bacchelli C, Beales PL. Managing Bardet-Biedl syndrome-now and in the future. Front Pediatr. 2018;6(February):1–8.
Hampshire DJ, Ayub M, Springell K, Roberts E, Jafri H, Rashid Y, et al. MORM syndrome (mental retardation, truncal obesity, retinal dystrophy and micropenis), a new autosomal recessive disorder, links to 9q34. Eur J Hum Genet. 2006;14(5):543–8.
Ritter A, Friemel A, Kreis NN, Hoock SC, Roth S, Kielland-Kaisen U, et al. Primary Cilia Are Dysfunctional in Obese Adipose-Derived Mesenchymal Stem Cells. Stem Cell Reports. 2018;10(2).
Bishop GA, Berbari NF, Lewis J MK. Type III adenylyl cyclase localizes to primary cilia throughout the adult mouse brain. J Comp Neurol. 2007;505(5):562–71.
Martínez-Hernández A, Enríquez L, Moreno-Moreno MJ, Martí A. Genetics of obesity. Public Health Nutr. 2007;10(10 A):1138–44.
Ling C, Rönn T. Epigenetics in Human Obesity and Type 2 Diabetes. Cell Metab. 2019 May 7;29(5):1028–44.
Samuel T. Keating and Assam. Epigenetics and Metabolism. Circ Res. 2015;116:715–37.